Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 11 results.
User Information
Export Records
  1. 1.   Development of a quantitative cell-based ELISA, for a humanized anti-IL-2/IL-15 receptor beta antibody (HuMik beta(1)), and correlation with functional activity using an antigen-transfected murine cell line
  2. Yang, X. Y.; Chen, E.; Jiang, H. G.; Hartmann, W. K.; Mitra, G.; Hecht, T.; Soman, G.
  3. Journal of Immunological Methods. 2006, APR 20; 311(1-2): 71-80.
  1. 2.   Development of a quantitative antigen-specific cell-based ELISA for the 7G7/B6 monoclonal antibody directed toward IL-2R alpha
  2. Yang, X. Y.; Jiang, H. G.; Hartmann, W. K.; Mitra, G.; Soman, G.
  3. Journal of Immunological Methods. 2003 277(1-2): 87-100.
  1. 3.   Cytokines: Past, present, and future
  2. Oppenheim, J. J.
  3. International Journal of Hematology. 2001 74(1): 3-8.
  1. 4.   IL-2-induced activation-induced cell death is inhibited in IL- 15 transgenic mice
  2. Marks-Konczalik, J.; Dubois, S.; Losi, J. M.; Sabzevari, H.; Yamada, N.; Feigenbaum, L.; Waldmann, T. A.; Tagaya, Y.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2000 97(21): 11445-11450.
  1. 5.   Immunoconjugates of geldanamycin and anti-HER2 monoclonal antibodies: Antiproliferative activity on human breast carcinoma cell lines
  2. Mandler, R.; Wu, C. C.; Sausville, E. A.; Roettinger, A. J.; Newman, D. J.; Ho, D. K.; King, C. R.; Yang, D. J.; Lippman, M. E.; Landolfi, N. F.; Dadachova, E.; Brechbiel, M. W.; Waldmann, T. A.
  3. Journal of the National Cancer Institute. 2000 92(19): 1573-1581.
  1. 6.   IL-2 signaling in human monocytes involves the phosphorylation and activation of p59(hck)
  2. Bosco, M. C.; Curiel, R. E.; Zea, A. H.; Malabarba, M. G.; Ortaldo, J. R.; Espinoza-Delgado, I.
  3. Journal of Immunology. 2000 164(9): 4575-4585.
  1. 7.   Phase I trial of recombinant immunotoxin anti-Tac(Fv)PE38 (LMB-2) in patients with hematologic malignancies
  2. Kreitman, R. J.; Wilson, W. H.; White, J. D.; Stetler-Stevenson, M.; Jaffe, E. S.; Giardina, S.; Waldmann, T. A.; Pastan, I.
  3. Journal of Clinical Oncology. 2000 18(8): 1622-1636.
  1. 8.   JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response
  2. Wang, L. H.; Kirken, R. A.; Erwin, R. A.; Yu, C. R.; Farrar, W. L.
  3. Journal of Immunology. 1999 162(7): 3897-3904.
  1. 9.   Tyrphostin AG-490 inhibits cytokine-mediated JAK3/STAT5a/b signal transduction and cellular proliferation of antigen-activated human T cells
  2. Kirken, R. A.; Erwin, R. A.; Taub, D.; Murphy, W. J.; Behbod, F.; Wang, L. H.; Pericle, F.; Farrar, W. L.
  3. Journal of Leukocyte Biology. 1999 65(6): 891-899.
  1. 10.   Cytotoxic Agents Directed to Peptide Hormone Receptors - Defining the Requirements For a Successful Drug
  2. Czerwinski, G.; Tarasov, N. I.; Michejda, C. J.
  3. Proceedings of the National Academy of Sciences of the United States of America. 1998 95(20): 11520-11525.
  1. 11.   Functional Role For the Myeloid Differentiation Antigen Cd14 in the Activation of Human Monocytes By Il-2
  2. Bosco, M. C.; Espinozadelgado, I.; Rowe, T. K.; Malabarba, M. G.; Longo, D. L.; Varesio, L.
  3. Journal of Immunology. 1997 159(6): 2922-2931.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel